Table 3.
Number of days alive and out of the hospital in the first 100 days after allogeneic transplantation by selected patient demographic factors. Data by graft source is presented in Figure 1.
Characteristic | N | Median days alive and out of hospital* |
Interquartile range |
P-value‡ |
---|---|---|---|---|
Pediatric, MAC HCT recipients | ||||
Recipient race | 0.05 | |||
White | 293 | 54 | 32–67 | |
Black | 35 | 38 | 0–61 | |
Other | 21 | 42 | 17–58 | |
Unknown | 19 | 53 | 29–66 | |
Lansky score at transplant | 0.17 | |||
≥ 80 | 355 | 53 | 28–66 | |
< 80 | 11 | 19 | 7–48 | |
Unknown | 2 | 37 | 22–52 | |
HCT-CI score | 0.99 | |||
0 | 287 | 52 | 27–66 | |
1–2 | 55 | 54 | 16–65 | |
≥ 3 | 26 | 49 | 34–63 | |
Diagnosis | 0.35 | |||
Acute myeloid leukemia | 169 | 54 | 28–67 | |
Acute lymphoblastic leukemia | 199 | 51 | 22–65 | |
Median household income† | .98 | |||
< $50,000 | 165 | 53 | 31–65 | |
$50,000–100,000 | 167 | 51 | 21–67 | |
≥ $100,000 | 20 | 53 | 40–61 | |
Unknown | 16 | 46 | 34–67 | |
Adult, MAC HCT recipients | ||||
Recipient race | <0.001 | |||
White | 662 | 70 | 47–79 | |
Black | 53 | 48 | 21–68 | |
Other | 41 | 66 | 45–73 | |
Unknown | 12 | 64 | 54–80 | |
Karnofsky score at transplant | 0.05 | |||
≥ 80 | 698 | 69 | 44–78 | |
< 80 | 59 | 54 | 38–80 | |
Unknown | 11 | 80 | 67–86 | |
HCT-CI score | 0.47 | |||
0 | 290 | 69 | 41–79 | |
1–2 | 244 | 69 | 45–79 | |
≥ 3 | 233 | 68 | 47–78 | |
Diagnosis | <0.001 | |||
Acute myeloid leukemia | 568 | 70 | 52–79 | |
Acute lymphoblastic leukemia | 200 | 60 | 29–76 | |
Median household income† | 0.18 | |||
< $50,000 | 294 | 68 | 36–77 | |
$50,000–100,000 | 410 | 70 | 52–79 | |
≥ $100,000 | 45 | 67 | 32–77 | |
Unknown | 19 | 68 | 44–80 | |
Adult, RIC HCT recipients | ||||
Recipient race | 0.05 | |||
White | 388 | 74 | 54–83 | |
Black | 22 | 70 | 43–78 | |
Other | 21 | 55 | 21–71 | |
Unknown | 10 | 72 | 24–78 | |
Karnofsky score at transplant | 0.008 | |||
≥ 80 | 402 | 73 | 51–82 | |
< 80 | 33 | 74 | 57–85 | |
Unknown | 6 | 50 | 48–81 | |
HCT-CI score | 0.52 | |||
0 | 132 | 75 | 54–83 | |
1–2 | 142 | 73 | 51–84 | |
≥ 3 | 167 | 73 | 50–81 | |
Diagnosis | 0.43 | |||
Acute myeloid leukemia | 394 | 74 | 53–83 | |
Acute lymphoblastic leukemia | 47 | 70 | 43–81 | |
Median household income† | 0.86 | |||
< $50,000 | 159 | 74 | 48–85 | |
$50,000–100,000 | 237 | 71 | 53–81 | |
≥ $100,000 | 33 | 76 | 59–82 | |
Unknown | 12 | 74 | 43–84 |
HCT – hematopoietic cell transplantation; MAC – myeloablative conditioning; RIC – reduced intensity conditioning; HCT-CI – hematopoietic cell transplant comorbidity index
Larger number indicates more days alive and out of hospital in the first 100 days after transplantation
Based on Zip code of patient residence (from the 2011 US Census American Community Survey data)
Univariate P-value